ArticleNeuro-oncology advances

Treatment of unmethylated MGMT-promoter recurrent glioblastoma with cancer stem cell assay-guided chemotherapy and the impact on patients' healthcare costs.

Tulika Ranjan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.